Pharmacogenetics of Acenocoumarol

The use of oral anticoagulation is marked by an elevated risk of adverse drug events (ADE) due to a narrow therapeutic window leading to important medical and economical consequences. The risk of ADE ...

Lead sponsor: University Hospital, Geneva•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDNA

Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum

NCT01588171 · Venous Thromboembolic Diseases

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 21, 2013Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment115

Start dateNov 2008

Last updatedJun 21, 2013

Condition

Thromboembolic Diseases

Locations shown

University Hospitals

Geneva

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 21, 2013Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions